EUR

Augustine Therapeutics on Wednesday announced it has raised EUR 17M ($18.5M) in the first closing of its Series A round. The financing was led by Asabys Partners, with participation from Eli Lilly and Company and Charcot-Marie-Tooth Research Foundation. The proceeds from this first close will be used to advance Augustine’sContinue Reading